Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
At individual level, increased concentrations of CCL4, CXCL10, CCL2, CXCL8, CRP, IL4, neutrophils, VEGF, and MDA were observed, along with decreased vitamin D levels.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A systematic review and meta-analysis
Source: Article title.
A systematic review and meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Altered blood-based biomarkers in carpal tunnel syndrome. A systematic review and meta-analysis
Systematic review · Musculoskeletal science & practice · 2026
Original publication title
Altered blood-based biomarkers in carpal tunnel syndrome. A systematic review and meta-analysis
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To comprehensively characterize blood-based biomarker alterations in CTS compared with healthy controls. A secondary aim was to summarize reported associations between biomarkers and clinical outcomes. Methods: Seven databases were searched from inception to February 2026. Two reviewers independently screened the included studies, extracted data and assessed methodological quality using the Newcastle: Ottawa Scale. Meta-analyses were performed when at least two comparable studies were available with a multilevel random-effects approach for the main meta-analyses, and random-effects or fixed-effects for subgroups metaanalyses. Sensitivity analyses were performed through “leave-one-out” method and certainty of evidence was evaluated through GRADE approach.
Source: ObjectivesAbstract: Results
Meta-analyses showed significantly higher blood levels of fibrosis-related markers [SMD (95% CI) = 1.64 (0.96/2.33)], anti-inflammatory markers [SMD (95% CI) = 1 (0.1/1.89)], proinflammatory markers [SMD (95% CI) = 0.63 (0.13/1.12)], and lower levels of vitamins and minerals [SMD (95% CI) = −0.75 (−1.49/-0.005)]. At individual level, increased concentrations of CCL4, CXCL10, CCL2, CXCL8, CRP, IL4, neutrophils, VEGF, and MDA were observed, along with decreased vitamin D levels.
Source: ResultsAbstract: Conclusion
CTS might be associated with systemic alterations in inflammatory and fibrotic pathways, and reduced vitamin D levels. Despite low certainty of evidence, high heterogeneity and the inability to confer causality from observational data, these biomarkers may inform future prospective research.
Source: ConclusionAuthors’ abstract
Introduction
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy, yet its pathophysiology remains unclear. Inflammation, fibrosis, and metabolic factors have been implicated in animal models, but evidence from human studies is inconsistent.
Objectives
To comprehensively characterize blood-based biomarker alterations in CTS compared with healthy controls. A secondary aim was to summarize reported associations between biomarkers and clinical outcomes. Methods: Seven databases were searched from inception to February 2026. Two reviewers independently screened the included studies, extracted data and assessed methodological quality using the Newcastle: Ottawa Scale. Meta-analyses were performed when at least two comparable studies were available with a multilevel random-effects approach for the main meta-analyses, and random-effects or fixed-effects for subgroups metaanalyses. Sensitivity analyses were performed through “leave-one-out” method and certainty of evidence was evaluated through GRADE approach.
Results
Meta-analyses showed significantly higher blood levels of fibrosis-related markers [SMD (95% CI) = 1.64 (0.96/2.33)], anti-inflammatory markers [SMD (95% CI) = 1 (0.1/1.89)], proinflammatory markers [SMD (95% CI) = 0.63 (0.13/1.12)], and lower levels of vitamins and minerals [SMD (95% CI) = −0.75 (−1.49/-0.005)]. At individual level, increased concentrations of CCL4, CXCL10, CCL2, CXCL8, CRP, IL4, neutrophils, VEGF, and MDA were observed, along with decreased vitamin D levels.
Conclusion
CTS might be associated with systemic alterations in inflammatory and fibrotic pathways, and reduced vitamin D levels. Despite low certainty of evidence, high heterogeneity and the inability to confer causality from observational data, these biomarkers may inform future prospective research.
Publication and source details
Original title: Altered blood-based biomarkers in carpal tunnel syndrome. A systematic review and meta-analysis
Jorge Menéndez-Cámara; Miguel Molina-Álvarez; Jesús Zabala-Zambrano; Alberto Arribas-Romano; Carmen Rodríguez-Rivera; Eva Fernández-Cobo; Josué Fernández-Carnero; Luis Matesanz-García; Annina B. Schmid
Musculoskeletal science & practice · 2026
* Corresponding author. Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, Alcorcón, Spain. josue.fernandez@urjc.es (J. Fernández-Carnero).https://creativecommons.org/licenses/by/4.0/This work is licensed under a CC BY 4.0 International license.https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:18:01.215443+00:00
DOI: 10.1016/j.msksp.2026.103561 · PMC7619193